Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo Re

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|November 6, 2019
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis StatusJessie Torgersen, Michael J Kallan, Dena M Carbonari, et al.
Plos One|July 23, 2025
Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokinesJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
BMJ Open|March 19, 2026
Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety studySruthi Adimadhyam, Dominique Luyts, Driss Oraichi, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2021
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel SystemNoelle M Cocoros, Candace C Fuller, Sruthi Adimadhyam, et al.
JAMA Network Open|December 14, 2022
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentLamia Y Haque, David A Fiellin, Janet P Tate, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
BMJ Open Diabetes Research & Care|September 8, 2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomesVincent Lo Re, Dena M Carbonari, M Elle Saine, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|November 6, 2019
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis StatusJessie Torgersen, Michael J Kallan, Dena M Carbonari, et al.
Plos One|July 23, 2025
Magnetic resonance evaluation of three-dimensional liver fat fraction by hepatitis C status and associations with inflammatory cytokinesJessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
BMJ Open|March 19, 2026
Postmarketing safety surveillance for GSK's AS01<sub>E</sub>-adjuvanted respiratory syncytial virus prefusion F protein-based vaccine in the USA: protocol for a non-interventional postauthorisation safety studySruthi Adimadhyam, Dominique Luyts, Driss Oraichi, et al.
Pharmacoepidemiology and Drug Safety|April 2, 2021
A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel SystemNoelle M Cocoros, Candace C Fuller, Sruthi Adimadhyam, et al.
JAMA Network Open|December 14, 2022
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentLamia Y Haque, David A Fiellin, Janet P Tate, et al.
Pharmacoepidemiology and Drug Safety|April 22, 2021
Validity of ICD-10-CM diagnoses to identify hospitalizations for serious infections among patients treated with biologic therapiesVincent Lo Re, Dena M Carbonari, Jerry Jacob, et al.
BMJ Open Diabetes Research & Care|September 8, 2017
Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomesVincent Lo Re, Dena M Carbonari, M Elle Saine, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
Pageof 20